Medicine guide

SAPHNELO

As listed in the register: SAPHNELO 300 mg, solution à diluer pour perfusion

300 mg · solution à diluer pour perfusion

  • Prescription only
Active substance
Anifrolumab
Made by
ASTRAZENECA AB

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byASTRAZENECA AB
Active substanceAnifrolumab
Strength300 mg
Formsolution à diluer pour perfusion
Routeintraveineuse
Dispensing (as stated by the register)réservé à l'usage HOSPITALIER · prescription réservée aux spécialistes et services MEDECINE INTERNE · prescription réservée aux spécialistes et services NEPHROLOGIE · prescription réservée aux spécialistes et services RHUMATOLOGIE · prescription réservée aux spécialistes et services DERMATOLOGIE · liste I
MarketedYes, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/21/1623
Name in the registerSAPHNELO 300 mg, solution à diluer pour perfusion
Packs1 flacon(s) en verre de 2 ml
CIS61365985
CIP133400955087366

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).